Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription


1 Ann Intern Med
1 Anticancer Res
1 Asian J Surg
1 Asian J Urol
1 Asian Pac J Cancer Prev
2 BJU Int
1 BMC Cancer
1 BMJ Case Rep
1 Cancer Genomics Proteomics
1 Drug Metab Rev
1 Eur J Cancer Prev
2 Eur Urol
1 Expert Rev Anticancer Ther
1 Free Radic Biol Med
1 Hum Pathol
1 In Vitro Cell Dev Biol Anim
1 In Vivo
1 Int J Cancer
1 Int J Environ Res Public Health
1 Int J Urol
1 J Huazhong Univ Sci Technolog Med Sci
1 J Med Ultrason (2001)
1 J Occup Environ Med
1 Medicine (Baltimore)
1 Molecules
1 Nat Commun
1 Nat Rev Clin Oncol
1 NPJ Genom Med
1 Oncol Lett
5 Oncotarget
1 Orv Hetil
1 Pan Afr Med J
1 Prostate
1 Radiother Oncol
2 Urol Oncol
1 Vet Immunol Immunopathol

    Ann Intern Med

  1. SAXE JS
    Ann Intern Med. 2017;167:828-829.
    >> Share

    Anticancer Res

  2. SOUKUP V, Capoun O, Pesl M, Sobotka R, et al
    Placental Growth Factor in Bladder Cancer Compared to the Diagnostic Accuracy and Prognostic Performance of Vascular Endothelial Growth Factor A.
    Anticancer Res. 2018;38:239-246.
    >> Share

    Asian J Surg

  3. MATSUMOTO K, Tabata KI, Hirayama T, Shimura S, et al
    Robot-assisted laparoscopic radical cystectomy is a safe and effective procedure for patients with bladder cancer compared to laparoscopic and open surgery: Perioperative outcomes of a single-center experience.
    Asian J Surg. 2017 Dec 15. pii: S1015-9584(17)30518.
    >> Share

    Asian J Urol

  4. SAADI A, Bouzouita A, Rebai MH, Cherif M, et al
    Superselective embolisation of bilateral superior vesical arteries for management of intractable hematuria in context of metastatic bladder cancer.
    Asian J Urol. 2017;4:131-134.
    >> Share

    Asian Pac J Cancer Prev

  5. AFSHARMOGHADAM N, Haghighatian Z, Mazdak H, Mirkheshti N, et al
    Concentration- Dependent Effects of Curcumin on 5-Fluorouracil Efficacy in Bladder Cancer Cells
    Asian Pac J Cancer Prev. 2017;18:3225-3230.
    >> Share

    BJU Int

  6. RITCH CR, Balise R, Soodana Prakash N, Alonzo D, et al
    Propensity matched comparative analysis of survival following chemoradiation or radical cystectomy for muscle invasive bladder cancer.
    BJU Int. 2017 Dec 27. doi: 10.1111/bju.14109.
    >> Share

  7. MIYAKE M, Tatsumi Y, Matsumoto H, Nagao K, et al
    Outcomes of subsequent non-muscle invasive bladder cancer treated with intravesical Bacillus Calmette-Guerin after radical nephroureterectomy for upper urinary tract urothelial carcinoma: A propensity matched analysis with primary bladder cancer.
    BJU Int. 2017 Dec 27. doi: 10.1111/bju.14111.
    >> Share

    BMC Cancer

  8. ZHANG Z, Zhang G, Gao Z, Li S, et al
    Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer.
    BMC Cancer. 2017;17:861.
    >> Share

    BMJ Case Rep

  9. PRICE L, Glynn P, Zarkar A
    Interstitial lung disease secondary to Cetuximab in bladder cancer: an Oncologist's perspective.
    BMJ Case Rep. 2017;2017.
    >> Share

    Cancer Genomics Proteomics

  10. ZHANG Q, Wang W, Xu W, DU M, et al
    Genetic Variations in the 3'-untranslated Regions of Genes Involved in the Cell Cycle and Apoptosis Pathways Affect Bladder Cancer Risk.
    Cancer Genomics Proteomics. 2018;15:67-72.
    >> Share

    Drug Metab Rev

  11. DHAINI HR, El Hafi B, Khamis AM
    NAT1 genotypic and phenotypic contribution to urinary bladder cancer risk: a systematic review and meta-analysis.
    Drug Metab Rev. 2017 Dec 19:1-12. doi: 10.1080/03602532.2017.1415928.
    >> Share

    Eur J Cancer Prev

  12. GUERCIO V, Turati F, Bosetti C, Polesel J, et al
    Bladder cancer risk in users of selected drugs for cardiovascular disease prevention.
    Eur J Cancer Prev. 2017 Dec 26. doi: 10.1097/CEJ.0000000000000419.
    >> Share

    Eur Urol

  13. PANG KH, Noon AP
    Re: Radical Cystectomy (Bladder Removal) Against Intravesical BCG Immunotherapy for High-risk Non-muscle Invasive Bladder Cancer (BRAVO): A Protocol for a Randomised Controlled Feasibility Study.
    Eur Urol. 2017 Dec 19. pii: S0302-2838(17)31039.
    >> Share

  14. SAITO R, Kobayashi T, Ogawa O
    Re: Comprehensive Molecular Characterization of Muscle-invasive Bladder Cancer.
    Eur Urol. 2017 Dec 20. pii: S0302-2838(17)31042.
    >> Share


    Discovering urinary bladder cancer risk variants: Status quo after almost ten years of genome-wide association studies.
    EXCLI J. 2017;16:1288-1296.
    >> Share

    Expert Rev Anticancer Ther

  16. SUNDAHL N, Rottey S, De Maeseneer D, Ost P, et al
    Pembrolizumab for the treatment of bladder cancer.
    Expert Rev Anticancer Ther. 2017 Dec 29:1-8. doi: 10.1080/14737140.2018.1421461.
    >> Share

    Free Radic Biol Med

  17. CIAMPORCERO E, Daga M, Pizzimenti S, Roetto A, et al
    Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer.
    Free Radic Biol Med. 2017 Dec 14. pii: S0891-5849(17)31237.
    >> Share

    Hum Pathol

  18. INAMURA K, Kobayashi M, Nagano H, Sugiura Y, et al
    A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder.
    Hum Pathol. 2017;69:96-100.
    >> Share

    In Vitro Cell Dev Biol Anim

  19. LEE YH, Yeh CH
    Laminar shear stress inhibits high glucose-induced migration and invasion in human bladder cancer cells.
    In Vitro Cell Dev Biol Anim. 2017 Dec 22. pii: 10.1007/s11626-017-0217.
    >> Share

    In Vivo

  20. SIRACUSANO S, D'Elia C, Cerruto MA, Saleh O, et al
    Quality of Life in Patients with Bladder Cancer Undergoing Ileal Conduit: A Comparison of Women Versus Men.
    In Vivo. 2018;32:139-143.
    >> Share

    Int J Cancer

  21. YU Y, Jin H, Xu J, Gu J, et al
    XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIbeta mRNA stability.
    Int J Cancer. 2017 Dec 18. doi: 10.1002/ijc.31223.
    >> Share

    Int J Environ Res Public Health

  22. PAVANELLO S, Carta A, Mastrangelo G, Campisi M, et al
    Relationship between Telomere Length, Genetic Traits and Environmental/Occupational Exposures in Bladder Cancer Risk by Structural Equation Modelling.
    Int J Environ Res Public Health. 2017;15.
    >> Share

    Int J Urol

  23. FUJII Y
    Prediction models for progression of non-muscle-invasive bladder cancer: A review.
    Int J Urol. 2017 Dec 16. doi: 10.1111/iju.13509.
    >> Share

    J Huazhong Univ Sci Technolog Med Sci

  24. LI B, Xie F, Zheng FX, Jiang GS, et al
    Overexpression of CircRNA BCRC4 regulates cell apoptosis and MicroRNA-101/EZH2 signaling in bladder cancer.
    J Huazhong Univ Sci Technolog Med Sci. 2017;37:886-890.
    >> Share

    J Med Ultrason (2001)

  25. KANDEMIRLI SG, Dikici AS, Nurili F, Tutar O, et al
    Bladder cancer in an inguinal vesical hernia.
    J Med Ultrason (2001). 2017 Dec 18. pii: 10.1007/s10396-017-0854.
    >> Share

    J Occup Environ Med

  26. JUNG YL, Tompa E, Longo C, Kalcevich C, et al
    The Economic Burden of Bladder Cancer due to Occupational Exposure.
    J Occup Environ Med. 2017 Dec 21. doi: 10.1097/JOM.0000000000001242.
    >> Share

    Medicine (Baltimore)

  27. XIAOQIANG L, Xuerong Z, Juan L, Mathew BS, et al
    Efficacy of pudendal nerve block for alleviation of catheter-related bladder discomfort in male patients undergoing lower urinary tract surgeries: A randomized, controlled, double-blind trial.
    Medicine (Baltimore). 2017;96:e8932.
    >> Share


  28. NEOH CA, Wu WT, Dai GF, Su JH, et al
    Flaccidoxide-13-Acetate Extracted from the Soft Coral Cladiella kashmani Reduces Human Bladder Cancer Cell Migration and Invasion through Reducing Activation of the FAK/PI3K/AKT/mTOR Signaling Pathway.
    Molecules. 2017;23.
    >> Share

    Nat Commun

  29. LIU D, Abbosh P, Keliher D, Reardon B, et al
    Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.
    Nat Commun. 2017;8:2193.
    >> Share

    Nat Rev Clin Oncol

  30. HURST CD, Knowles MA
    Bladder cancer: Multi-omic profiling refines the molecular view.
    Nat Rev Clin Oncol. 2017 Dec 19. pii: nrclinonc.2017.
    >> Share

    NPJ Genom Med

  31. OKHOLM TLH, Nielsen MM, Hamilton MP, Christensen LL, et al
    Circular RNA expression is abundant and correlated to aggressiveness in early-stage bladder cancer.
    NPJ Genom Med. 2017;2:36.
    >> Share

    Oncol Lett

  32. HO JN, Kang M, Lee S, Oh JJ, et al
    Anticancer effect of S-allyl-L-cysteine via induction of apoptosis in human bladder cancer cells.
    Oncol Lett. 2018;15:623-629.
    >> Share


  33. PENG F, Li H, Xiao H, Li L, et al
    Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer.
    Oncotarget. 2017;8:105553-105560.
    >> Share

  34. WANG Z, Que H, Suo C, Han Z, et al
    Evaluation of the NMP22 BladderChek test for detecting bladder cancer: a systematic review and meta-analysis.
    Oncotarget. 2017;8:100648-100656.
    >> Share

  35. KO K, Jeong CW, Kwak C, Kim HH, et al
    Significance of Ki-67 in non-muscle invasive bladder cancer patients: a systematic review and meta-analysis.
    Oncotarget. 2017;8:100614-100630.
    >> Share

  36. CHAN OTM, Furuya H, Pagano I, Shimizu Y, et al
    Association of MMP-2, RB and PAI-1 with decreased recurrence-free survival and overall survival in bladder cancer patients.
    Oncotarget. 2017;8:99707-99721.
    >> Share

  37. XU X, Li J, Zhu Y, Xie B, et al
    CRISPR-ON-Mediated KLF4 overexpression inhibits the proliferation, migration and invasion of urothelial bladder cancer in vitro and in vivo.
    Oncotarget. 2017;8:102078-102087.
    >> Share

    Orv Hetil

  38. KLITON J, Polgar C, Tenke P, Kovacs G, et al
    [Image-guided radiotherapy for muscle invasive bladder cancer with intravesical lipiodol injection. A new option for bladder sparing treatment].
    Orv Hetil. 2017;158:2041-2047.
    >> Share

    Pan Afr Med J

  39. TOUZANI MA, Yddoussalah O
    [Cavernous metastasis from blader tumor].
    Pan Afr Med J. 2017;28:60.
    >> Share


  40. DAVIDSSON S, Andren O, Ohlson AL, Carlsson J, et al
    FOXP3+ regulatory T cells in normal prostate tissue, postatrophic hyperplasia, prostatic intraepithelial neoplasia, and tumor histological lesions in men with and without prostate cancer.
    Prostate. 2017 Nov 6. doi: 10.1002/pros.23442.
    >> Share

    Radiother Oncol

  41. CHARGARI C, Martelli H, Guerin F, Bacorro W, et al
    Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: Compliance and early clinical results.
    Radiother Oncol. 2017;124:285-290.
    >> Share

    Urol Oncol

  42. BOOTH CM, Karim S, Brennan K, Siemens DR, et al
    Perioperative chemotherapy for bladder cancer in the general population: Are practice patterns finally changing?
    Urol Oncol. 2017 Dec 15. pii: S1078-1439(17)30603.
    >> Share

  43. SUSSMAN RD, Han CJ, Marchalik D, Carvahlo FL, et al
    To oophorectomy or not to oophorectomy: Practice patterns among urologists treating bladder cancer.
    Urol Oncol. 2017 Dec 19. pii: S1078-1439(17)30606.
    >> Share

    Vet Immunol Immunopathol

  44. INOUE A, Maeda S, Kinoshita R, Tsuboi M, et al
    Density of tumor-infiltrating granzyme B-positive cells predicts favorable prognosis in dogs with transitional cell carcinoma.
    Vet Immunol Immunopathol. 2017;190:53-56.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016